Increase of vertebral density by combination therapy with pulsatile 1-38hPTH and sequential addition of calcitonin nasal spray in osteoporotic patients

Calcified Tissue International
R D HeschE F Rittinghaus

Abstract

Combination therapy with the biologically active (1-38) human parathyroid hormone peptide and calcitonin using pulsatile and sequential activation of the skeleton for 14 months in patients with low-turnover osteoporosis resulted in an increase in trabecular bone mass. These favorable responses were observed without any significant changes in cortical (forearm) bone mass content.

References

Nov 15, 1979·The New England Journal of Medicine·K J MartinE Slatopolsky
Mar 1, 1985·Journal of Clinical Pathology·T J Chambers
Aug 1, 1986·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·D M SlovikR M Neer
Jul 19, 1974·Nature·J A Parsons, B Reit
Dec 10, 1965·Science·J Friedman, L G Raisz
Oct 1, 1984·Hormone and Metabolic Research = Hormon- Und Stoffwechselforschung = Hormones Et Métabolisme·R D HeschM J Atkinson
Feb 1, 1981·The Journal of Clinical Investigation·G V SegreJ t Potts
Oct 1, 1981·Biochemical Society Transactions·J A ParsonsR W Stevenson

❮ Previous
Next ❯

Citations

Sep 1, 1990·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·C C Liu, D N Kalu
Sep 1, 1993·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·C EjerstedM H Nilsson
Aug 1, 1994·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R H RixonW Sung
Dec 1, 1994·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J P CasezP Jaeger
Mar 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Y F MaN Yamamoto
Apr 1, 1996·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·B H MitlakR M Neer
Apr 1, 1996·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·J Reeve
Jan 1, 1993·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J ReeveJ M Zanelli
Jan 11, 1991·Calcified Tissue International·J H Carstens, J D Feinblatt
Jan 1, 1997·Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA·J Y ReginsterB Zegels
Jul 23, 2005·Current Osteoporosis Reports·Marie-Paul LecartJean-Yves Reginster
Oct 1, 1990·Mechanisms of Ageing and Development·D N KaluB W Hollis
Jan 1, 1990·Experimental Gerontology·E F RittinghausG Delling
Dec 15, 1994·The New England Journal of Medicine·J S FinkelsteinR M Neer
Jun 16, 2005·Current Opinion in Rheumatology·Nancy Lane, Stephen Morris
Dec 1, 1992·The Journal of Clinical Investigation·T Naveh-ManyJ Silver
Mar 1, 1997·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Y IshikawaR E Wuthier
Mar 1, 1997·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·R Armamento-VillarealR Civitelli
Apr 1, 1997·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·M H SamuelsG R Mundy
Jul 5, 2002·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Armen H Tashjian, Bruce A Chabner
Apr 20, 2001·Journal of Clinical Densitometry : the Official Journal of the International Society for Clinical Densitometry·M P AkhterR R Recker
Apr 1, 2005·Treatments in Endocrinology·James F WhitfieldGordon E Willick
Nov 15, 2001·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·T Fujita
Nov 4, 2000·Expert Opinion on Investigational Drugs·J WhitfieldG Willick
Jun 1, 1997·Expert Opinion on Investigational Drugs·J W Dietrich
Aug 11, 2012·Endocrinology and Metabolism Clinics of North America·Alexander V Uihlein, Benjamin Z Leder
Aug 2, 2005·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·Camilo JimenezRobert F Gagel
Nov 30, 1993·The American Journal of Medicine·B L Riggs
May 23, 2006·Metabolism: Clinical and Experimental·Gherardo MazziottiAndrea Giustina
Oct 1, 1993·Baillière's Clinical Rheumatology·M S Marsh, J C Stevenson
Apr 5, 2001·Rheumatic Diseases Clinics of North America·C J Rosen, P J Rackoff
Aug 15, 2003·Clinics in Geriatric Medicine·Mishaela R Rubin, John P Bilezikian
Jun 15, 1993·Analytical Chemistry·N A McCarroll

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
J ReeveJ P Ashby
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
D M SlovikRobert M Neer
© 2022 Meta ULC. All rights reserved